Evidence map›Paper›PMID 30682224›Full record

ArticleEpilepsia2019

Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.

McKenna Kelly, Meredith Park, Ivana Mihalek, Anne Rochtus, Marie Gramm, Eduardo Pérez-Palma, Erika Takle Axeen, Christina Y Hung, Heather Olson, Lindsay Swanson and 14 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Epilepsia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Decoding GNAO1 mutations usingFrontiers in cellular neuroscience · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 2 countries.

McKenna KellyEpilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Meredith ParkEpilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Ivana MihalekDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts.
Anne RochtusEpilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Marie GrammCologne Center for Genomics, Cologne, Germany.
Eduardo Pérez-PalmaCologne Center for Genomics, Cologne, Germany.
Erika Takle AxeenEpilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Christina Y HungDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts.
Heather OlsonEpilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Lindsay SwansonDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Irina AnselmDepartment of Neurology, Harvard Medical School, Boston, Massachusetts.
Lauren C BriereDepartment of Medical Genetics, Massachusetts General Hospital, Boston, Massachusetts.
Frances A HighDepartment of Medical Genetics, Massachusetts General Hospital, Boston, Massachusetts.
David A SweetserDepartment of Medical Genetics, Massachusetts General Hospital, Boston, Massachusetts.
Undiagnosed Diseases Network
Saima KayaniDepartment of Pediatrics, Neurology, and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas.
Molly SnyderDepartment of Neurology, Children's Health, Dallas, Texas.
Sophie CalvertNeuroscience Department, Lady Cilento Children's Hospital, Brisbane, Queensland, Australia.
Ingrid E SchefferFlorey and Murdoch Children's Research Institute, Austin Health and Royal Children's Hospital, University of Melbourne, Melbourne, Victoria, Australia.
Edward YangDepartment of Radiology, Boston Children's Hospital, Boston, Massachusetts.
Jeff L WaughDepartment of Neurology, Harvard Medical School, Boston, Massachusetts.
Dennis LalCologne Center for Genomics, Cologne, Germany.
Olaf BodamerDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts.
Annapurna PoduriEpilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Boston Children's Hospital · USBroad Institute · USMassachusetts General Hospital · USThe University of Texas Southwestern Medical Center · USDartmouth College · USMedical City Children's Hospital · USRoyal Children's Hospital · AU

Funding

Center for Integrated Approaches to Undiagnosed DiseasesU01HG007690 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI LOSCALZO, JOSEPH · 2014 to 2022
$10.4M
Clinical Sequencing Core Facility for the Undiagnosed Diseases Network (UDN)U01HG007942 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI ENG, CHRISTINE · 2014 to 2021
$10.2M
Diagnosis and Genotype-Phenotype Correlations in Early Life Epilepsy and CDKL5 DisorderK23NS107646 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI OLSON, HEATHER ELISA · 2018 to 2023
$1.2M
NHGRI NIH HHS U01 HG007690NHGRI NIH HHS U01 HG007942NIH HHS U01HG007690NIH HHS U01HG007942NINDS NIH HHS K23 NS107646
6 · The paper itself

Abstract

objectiveTo characterize the phenotypic spectrum associated with GNAO1 variants and establish genotype-protein structure-phenotype relationships.

methodsWe evaluated the phenotypes of 14 patients with GNAO1 variants, analyzed their variants for potential pathogenicity, and mapped them, along with those in the literature, on a three-dimensional structural protein model.

resultsThe 14 patients in our cohort, including one sibling pair, had 13 distinct, heterozygous GNAO1 variants classified as pathogenic or likely pathogenic. We attributed the same variant in two siblings to parental mosaicism. Patients initially presented with seizures beginning in the first 3 months of life (8/14), developmental delay (4/14), hypotonia (1/14), or movement disorder (1/14). All patients had hypotonia and developmental delay ranging from mild to severe. Nine had epilepsy, and nine had movement disorders, including dystonia, ataxia, chorea, and dyskinesia. The 13 GNAO1 variants in our patients are predicted to result in amino acid substitutions or deletions in the GNAO1 guanosine triphosphate (GTP)-binding region, analogous to those in previous publications. Patients with variants affecting amino acids 207-221 had only movement disorder and hypotonia. Patients with variants affecting the C-terminal region had the mildest phenotypes. SIGNIFICANCE: GNAO1 encephalopathy most frequently presents with seizures beginning in the first 3 months of life. Concurrent movement disorders are also a prominent feature in the spectrum of GNAO1 encephalopathy. All variants affected the GTP-binding domain of GNAO1, highlighting the importance of this region for G-protein signaling and neurodevelopment.

Indexed as

AdolescentCase-Control StudiesChildChild, PreschoolEpilepsyFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenetic VariationGTP-Binding Protein alpha Subunits, Gi-GoHumansMaleNeurodevelopmental DisordersYoung AdultGNAO1 protein, humanGTP-Binding Protein alpha Subunits, Gi-Godevelopmental and epileptic encephalopathyGNAO1mosaicismmovement disorders

Identifiers

PMID30682224
PMCPMC6452443
OpenAlexW2913607662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.